Riskpilot← Back to searchSign inGet full accessProzema AB
ABActiveOrg 5567329486Sveavägen 83 1105Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 20070 employees
Revenue 2025
SEK 0
EBITDA margin
—
-7% vs 2024
Equity ratio
31.3%
Financial strength
Net profit 2025
SEK -21K
+39% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -9K | -7% |
| Net profit | SEK -21K | +39% |
| Total assets | SEK 3,9M | +2% |
| Equity | SEK 1,2M | -2% |
| Employees | 0 | — |
Legal name
Prozema AB
Org number
5567329486
Legal form
Aktiebolag
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
29 juni 2007
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall äga och förvalta aktier, obligationer och andra värdepapper, äga och förvalta fast och lös egendom, köpa och försälja patent och ädla metaller och idka med angivna verksamheter förenlig verksamhet.
Address
Sveavägen 83 1105
Email
kristina@gardler.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −18 | −11 | −11 | −9 | −9 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −18 | −11 | −11 | −9 | −9 |
| Net financials | −64 | −3 | −8 | −25 | −11 |
| Profit before tax | −33 | −14 | −18 | −34 | −21 |
| Tax | −0 | — | — | — | — |
| Net profit | −33 | −14 | −18 | −34 | −21 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 584 | 3 670 | 3 747 | 3 851 | 3 915 |
| Equity | 1 310 | 1 296 | 1 278 | 1 244 | 1 224 |
| Long-term debt | 2 178 | 2 234 | 2 322 | 2 439 | 2 535 |
| Short-term debt | 96 | 141 | 148 | 167 | 156 |
| Total debt | 2 274 | 2 374 | 2 469 | 2 607 | 2 691 |
EBITDA margin
-937500.0%
This company
15.8%
Market median
-5933644% vs market
20212025
Equity ratio
31.3%
This company
38.2%
Market median
+18% vs market
20212025
Return on equity
-1.7%
This company
18.4%
Market median
-109% vs market
20212025
Net profit margin
-2059600.0%
This company
8.1%
Market median
-25427260% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
2.20×
This company
0.62×
Market median
-255% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Prozema AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claes Filip Gardler | Deputy Board Member | 0 companies |
| Rut Kristina Maria Gardler | Board of Directors | 0 companies |